On March 2, 2015, CollabRx, Inc. (the "Company") received the formal determination of the NASDAQ Listing Qualifications Panel indicating that the Company has satisfied all requirements for continued listing on the NASDAQ Capital Market, including the minimum $2.5 million stockholders' equity requirement. Accordingly, the hearing matter has been closed.
they were included in fully diluted share count so No additional diltion..BAM Going much higher.
5-10 baggers very successful.
Accumulate on dips before ASCO.
great company and management.
3 strong months for Longs as well as the entire year.
Do the math and measure all metrics..If you don't know please do not post garbage.
neurosurgery.ucla.edu/site.cfm?id=1433 ( Watch that video !
It is NWBO and its trilas at MD Anderson that are grabbing this news not ZIOP. But you can spin anyway u want.
and strong support. They are taking out all profit takers on the way up !